Accellent names new COO, president
Massachusetts medtech manufacturer Accellent Inc. shuffled its C-Suite, promoting Jeremy Friedman from CFO to president and COO of the cardio & vascular business, in addition to his duties as executive vice president.
His CFO role was filled in the interim by by Richard Johnson, the company’s principal financial officer and principal accounting officer.
Needham snags top analyst for research role
New York’s Needham & Co. hired former Mizuho Securities and Wells Fargo Securities analyst Mike Matson as its new senior research analyst covering medical device technologies and diagnostics.
Matson was named FT/StarMine World’s 2013 top analyst for earnings estimates in the medtech industry.
Covidien names new board member
Covidien (NYSE:COV) appointed Stephen Rusckowski as a new director of the Massachusetts-based company, effective December 1, 2013. Read more
Mazor promotes Prentice to global marketing SVP
Mazor Robotics (PINK:MZRTF) named Christopher Prentice its senior vice president of American and global marketing, taking on new duties in addition to continuing oversight of Mazor’s global marketing strategy.
InspireMD names new global marketing & strategy veep
Boston-based InspireMD (OTC:NSPR) appointed David Blossom its new global marketing & strategy vice president, tasking him with implementing an international marketing plan for the company’s coronary, carotid artery and vascular technologies.